Marcel Ruzicka
Overview
Explore the profile of Marcel Ruzicka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
2116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Landry C, Dubrofsky L, Pasricha S, Ringrose J, Ruzicka M, Tran K, et al.
Am J Hypertens
. 2024 Dec;
PMID: 39661401
Background: Cuffless blood pressure (BP) devices are an emerging technology marketed as providing frequent, non-intrusive and reliable BP measurements. With the increasing interest in these devices, it is important for...
2.
Bugeja A, Girard C, Sood M, Kendall C, Sweet A, Singla R, et al.
J Intern Med
. 2024 Jul;
296(3):280-290.
PMID: 38975673
Background: Sex-based disparities in cardiovascular outcomes may be improved with appropriate hypertension management. Objective: To compare the evidence-based evaluation and management of females with late-onset hypertension compared to males in...
3.
Bugeja A, Girard C, Sood M, Kendall C, Sweet A, Singla R, et al.
Hypertension
. 2024 Apr;
81(7):1583-1591.
PMID: 38660798
Background: It is unclear whether sex-based differences in cardiovascular outcomes exist in late-onset hypertension. Methods: This is a population-based cohort study in Ontario, Canada of 266 273 adults, aged ≥66...
4.
Lui S, Dubrofsky L, Khan N, Tobe S, Huynh J, Kuyper L, et al.
CJC Open
. 2024 Jan;
5(12):907-915.
PMID: 38204853
Background: The hypertension specialist often receives referrals of patients with young-onset, severe, difficult-to-control hypertension, patients with hypertensive emergencies, and patients with secondary causes of hypertension. Specialist hypertension care compliments primary...
5.
Ruzicka M, Hiremath S
Am J Kidney Dis
. 2023 Dec;
83(4):546-548.
PMID: 38081406
No abstract available.
6.
Hundemer G, Agharazii M, Madore F, Vaidya A, Brown J, Leung A, et al.
Circulation
. 2023 Nov;
149(2):124-134.
PMID: 38031887
Background: Primary aldosteronism, characterized by overt renin-independent aldosterone production, is a common but underrecognized form of hypertension and cardiovascular disease. Growing evidence suggests that milder and subclinical forms of primary...
7.
Sriperumbuduri S, Welling P, Ruzicka M, Hundemer G, Hiremath S
Am J Hypertens
. 2023 Sep;
37(2):91-100.
PMID: 37772757
Hypertension is the single most important and modifiable risk factor for cardiovascular morbidity and mortality worldwide. Non pharmacologic interventions, in particular dietary modifications have been established to decrease blood pressure...
8.
Chan R, Parikh N, Ahmed S, Ruzicka M, Hiremath S
Hypertension
. 2023 Aug;
81(3):501-509.
PMID: 37641923
No abstract available.
9.
Carrillo A, Akerman A, Notley S, Herry C, Seely A, Ruzicka M, et al.
Appl Physiol Nutr Metab
. 2023 Aug;
48(11):863-869.
PMID: 37556854
During short bouts of light-to-vigorous exercise in the heat, controlled and uncomplicated hypertension did not significantly modulate HRV in physically active individuals. These findings can be used to refine guidance...
10.
Bourque G, Ilin J, Ruzicka M, Hundemer G, Shorr R, Hiremath S
Am J Hypertens
. 2023 Jan;
36(7):394-403.
PMID: 36715101
Background: The prevalence of medication nonadherence in the setting of resistant hypertension (RH) varies from 5% to 80% in the published literature. The aim of this systematic review was to...